Research has shown that high expression of FGF1 and its receptors (FGFRs) in the lungs of patients with idiopathic pulmonary fibrosis (IPF) activates the MAPK signaling pathway, promoting fibrosis [27]. This evidence concerns the gene FGF1 and idiopathic pulmonary fibrosis.